Drug Profile
BlockAide/VP
Alternative Names: BlockAide/VPLatest Information Update: 30 Jan 2007
Price :
$50
*
At a glance
- Originator National Institutes of Health (USA); University of Texas M. D. Anderson Cancer Center
- Class
- Mechanism of Action HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 30 Jan 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 07 Oct 2003 Preclinical trials in HIV infections treatment in USA (unspecified route)